Akebia Therapeutics
AKBA
#6963
Rank
S$0.54 B
Marketcap
$2.57
Share price
4.02%
Change (1 day)
112.58%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$0.88

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.85. In 2022 the company made an earnings per share (EPS) of -$0.68 an increase over its 2021 EPS that were of -$2.26.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.8830.66%
2022-$0.68-70%
2021-$2.26-38.63%
2020-$3.6817.37%
2019-$3.132.79%
2018-$3.0531.2%
2017-$2.32-51.39%
2016-$4.7857.89%
2015-$3.03-94.83%
2014-$58.54589.75%
2013-$8.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.78-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.96-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$18.69-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.16 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA